International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.12781987
Original Research Article
Comparative Study on Short Term and Long Term Antibiotic Prophylaxis in Obstetrics and Gynaecological Surgeries
Published
Feb. 26, 2025
Abstract

Background: Postoperative infections remain a significant challenge in obstetrics and gynecological surgeries, leading to increased hospital stays and healthcare costs. Antibiotic prophylaxis aims to reduce microbial colonization during surgery. This study compares the effectiveness of short-term and long-term antibiotic regimens in preventing infections following elective caesarean sections and abdominal hysterectomies. Methods: An interventional prospective study was conducted over a year with 100 participants. Group 1 (50 patients) received a short-term regimen of ceftriaxone, while Group 2 (50 patients) underwent a long-term regimen. Key metrics, including wound infection rates, febrile morbidity, duration of hospital stay, and the need for additional antibiotics, were analyzed. Results: Wound infections were more frequent in Group 1 (14%) compared to Group 2 (2%), with febrile morbidity similarly higher in Group 1 (16% vs. 4%). The mean hospital stay was significantly shorter for Group 1 (3.12 days vs. 5.24 days). However, Group 2 demonstrated better infection control overall. Conclusion: While both regimens were effective, the short-term regimen was associated with reduced hospital stay and costs but increased infection rates. Long-term antibiotics offered superior infection control but at the expense of prolonged hospitalization and higher risk of nosocomial infections. Patient selection remains critical in determining the appropriate prophylactic approach.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
402 Views
96 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved